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Abstract
An essential component of animal cells, cholesterol exerts significant influence on
the physical properties of the cell membrane and in turn, its constituents. One such
category of constituents, the membrane proteins, are responsible for diverse and essential
biological functions and often contain polar amino acids. Although sparse within the
hydrophobic interior of lipid-bilayer membranes, polar amino acid residues are highly
conserved and may play pivotal roles in determining specific structural and functional
properties of key proteins. To gain greater understanding of the lipid membrane
environment, and more broadly, cellular function, a model peptide framework termed
“GWALP23” (acetyl-GGALWLALALAL12AL14ALALWLAGA-amide) can be useful.
Designed and created at the University of Arkansas, the peptide is composed of amino
acid residues of glycine (G), tryptophan (W), alanine (A), and leucine (L). The central
helical core consisting of the W(LA)6LW sequence is critical for defining the
transmembrane configuration of this host peptide framework. Furthermore, the limited
dynamic averaging of NMR observables such as the deuterium quadrupolar splittings of
labeled alanine residues makes GWALP23 favorable for examining the influence of
single “guest” residue replacements within the core sequence. Previously, GWALP23
family peptides were characterized with single leucine to arginine (R) mutations at
positions 12 and 14 in single-lipid membranes.1 GWALP23-R14 adopts a defined tilted
orientation in DOPC bilayers, whereas GWALP23-R12 displays multi-state behavior.1
The goal of this research is to further characterize these peptides in cholesterol-containing
lipid bilayers. Specific deuterium-labeled alanine residues were incorporated into the R12
and R14 sequences to identify transmembrane peptide orientations by means of solid-
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state deuterium NMR spectroscopy. The peptides were incorporated into phospholipid
bilayers with varying cholesterol content (0%, 10%, or 20%). Our findings suggest that
10% or 20% cholesterol content has minimal impact on the orientation of the GWALP23R14 peptide. (Although the NMR signals are broader and weaker in the presence of 20%
cholesterol, the deuterium quadrupolar splittings for 2H-Ala residues in GWALP23-R14
change little.) Conversely, cholesterol appears to reduce the multi-state behavior of
GWALP23-R12, favoring a single well-defined state for the helix. With 10% or 20%
cholesterol content, the spectra exhibit defined quadrupolar splittings, suggesting that
GWALP23-R12 adopts a predominant orientation at the membrane surface in the
presence of cholesterol. These results convey a conditional sensitivity of a complex
multi-state peptide helix to the presence of cholesterol.
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Abbreviations
CD, circular dichroism; DLPC, 1,2-dilauroylphosphatidylcholine; DMPC, 1,2dimyristoylphosphatidylcholine; DOPC, 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine;
Fmoc, fluorenylmethoxycarbonyl; GALA, geometric analysis of labeled alanines;
GWALP23, acetyl-GGALW(LA)6LWLAGA-[ethanol]amide; HPLC, high-performance
liquid chromatography; kHz, kilohertz; MALDI-TOF, matrix-assisted laser
desorption/ionization-time of flight; MtBE, methyl-t-butyl ether; NMR, nuclear magnetic
resonance; TFA, trifluoroacetic acid; TFE, 2,2,2-trifluoroethanol; TIPS, triisopropylsilane
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Introduction
Upon the discovery and continuing investigations of their vital roles in both disease
and basic cell functioning, membrane-bound proteins have become an increasingly
important focus of scientific research. Essential to many membrane proteins are polar
amino acids, which often determine the structure and function of the protein itself. The
particular sequence and length of a largely hydrophobic membrane protein determines its
behavior and stability within the cell membrane. Interestingly, the more sparse polar
amino acids may be critical for particular functional properties. The examination of polar
amino acids is possible through the use of synthetic model peptides such as those of the
“GWALP” family. The GWALP peptides were
created from an original “WALP” model peptide
family by reducing the number of tryptophan (W)
residues. WALP contained four aromatic W
residues that serve as anchors for the membranespanning helix.2,3,4 Although the WALP peptides
have been useful for studying peptide mismatch,
their high dynamics made them less than ideal for
studying the effects of single residue replacement
within the peptide core.5
GWALP23 was developed as a control and
was found to decrease the high dynamics of WALP
(Figure 1). By including only two anchoring

Figure 1. 3D representation
of model peptide GWALP23.
The indole rings extending
from the right side are W5 and
W19 in the 23-residue
sequence.

tryptophan residues (W) rather than the four contained in WALP, greater stability and
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lower dynamics were achieved.6,7 GWALP23 (GGALW(LA)6LWLAGA) contains a
single tryptophan residue at each end (positions 5 and 19) and a repeating leucine-alanine
helical core sequence.8,9 The leucine-alanine helical core prefers the hydrophobic
environment of the membrane, while the tryptophan residues prefer a location near the
lipid-water interface.10 GWALP23 and related model peptides fold into helices and adopt
defined tilted orientations that can be observed in bilayer membranes by means of solidstate NMR spectroscopy. The solid-state NMR spectra allow for investigations of just
one “guest” residue, such as a strongly polar or charged amino acid within the central
core of the transmembrane helix. The constrained dynamics of GWALP23 make it more
favorable than many other candidate “host” peptides for studies of specific guest residues.
Alanine residues within the GWALP23 core are labeled with deuterium in order to
study the dynamics and orientation of the peptide by means of solid-state deuterium (2H)
NMR spectroscopy. For convenience and experimental efficiency, alanine residues are
labeled in pairs in core positions as
follows: 7 and 9, 11 and 13, or 15 and 17.

Ala 100%

Within the alanine pairs that are labeled,
the alanine closest to the N terminus is

Ala 50%

labeled with 50% deuterium. The other
alanine is labeled with 100% deuterium.
This is so that quadrupolar splittings in
NMR spectra may be distinguished and
assigned, as shown in Figure 2.

50

-50 kHz

Figure 2. Deuterated alanine residues
are incorporated into the core of the
peptide with 50% or 100% relative
abundance to distinguish the
quadrupolar splittings by solid-state
deuterium NMR spectroscopy.
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The first focus of this project is to study the effects of replacing a single
hydrophobic leucine residue (L) with the very polar, and positively charged, arginine (R)
at position 14 of the GWALP23 peptide. Previous experiments have shown that R14
causes a 10° change in helix tilt, which is invariant over a pH range of 4 to 9, where the
arginine is charged.1 The equivalent peptide with lysine at position 14 (GWALP23-K14)
shows an interesting pH-dependent tilt that indicates a pKa of 6.5 for the lysine at 37°C in
membranes of DOPC.11 Based on the established titration of the lysine, my project has
focused on extending the NMR observations for GWALP23-R14 to higher pH, by using
bilayers composed of the more stable ether-linked lipids. The ether-linked DOPC bilayers
are used as a means of preventing the base-catalyzed hydrolysis of ester lipids. Deuterium
labels are incorporated in alanine residues 15 and 17 in GWALP23-R14 and the
magnitude and orientation of the helical tilt was assessed using solid-state deuterium
NMR spectroscopy at pH 9.5 and above.
This research project has also been directed to studying GWALP23-R14 and
GWALP23-R12 in cholesterol-containing lipid bilayer membranes. Calculations based
on questionable approximations for the lipid-bilayer environment have suggested that
cholesterol may have a direct effect on the pKa of buried arginine residues; perhaps
shifting the pKa of arginine from 12.5 to 3.8 in the presence of cholesterol.12 Using a
combination of DOPC phospholipids and cholesterol, I conducted experiments on
GWALP23-R14 and GWALP23-R12 using 0%, 10%, and 20% cholesterol content
(relative to the major lipid component DOPC) in the lipid bilayer.
The results of this research are important for understanding the effect of a changing
chemical environment on the ionization behavior of arginine and, more generally, the
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basic properties of proteins in cell membranes. Arginine plays an important role in cellto-cell communication. If the functioning of arginine is better understood in a realistic
cell environment, this will serve as an invaluable resource for computational scientists
modeling arginine-containing systems, as well as for researchers working to advance
drug design and delivery mechanisms. The sequences of model peptides used in this
research are shown in Table 1 and cartoon representations of peptides GWALP23-R12
and GWALP23-R14 are displayed in Figure 3.

A

B

Figure 3. Side view and top-down
representations of peptides (A) GWALP23-R12
and (B) GWALP23-R14.
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Table 1. Model Peptide Sequences: Table 1 displays the sequence of model peptide
GWALP23 as well as the sequences of model peptides I have synthesized (GWALP23R12 and GWALP23-R14). Deuterated alanine residues are denoted as A#.
Peptide Name

Sequence

GWALP23

acetyl-GGALWLALALALALALALWLAGA-amide

GWALP23-R12
GWALP23-R12
GWALP23-R14
GWALP23-R14

acetyl-GGALWLA7LA9LARALALALWLAGA-amide
acetyl-GGALWLALALARALA15LA17LWLAGA-amide
acetyl-GGALWLALALA11LA13RALALWLAGA-amide
acetyl-GGALWLALALALARA15LA17LWLAGA-amide
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Materials and Methods
Solid Phase Peptide Synthesis
Peptides containing deuterium-labeled alanine residues were synthesized using
an Applied Biosystems 433A Peptide Synthesizer.13 Fmoc-ala-d4 was created and
recrystallized in the lab, using a process which takes several weeks.8 To create peptides
by solid-phase peptide synthesis, 0.57 mmole of each amino acid in the peptide sequence
was obtained (weighed with a balance) and placed in an individual cartridge (one per
amino acid). The two alanine residues in the peptide sequence labeled with deuterium
were labeled in different proportions. One alanine was labeled with 50% deuterium
(0.285 mmoles of Fmoc-ala-d4 and 0.285 mmoles of alanine) and the other was labeled
with 100% deuterium (0.57 mmoles Fmoc-ala-d4). Alanine residues were labeled in pairs
at positions 7 and 9, 11 and 13, and 15 and 17. The amino acid cartridges are placed in
order from C to N-terminal in the delivery system of the peptide synthesizer. Thus,
peptides are synthesized from the carboxyl terminus back to the amino terminus.
“FastMoc” chemistry method was used to remove blocking groups, couple the amino
acids in the proper order, and thereby perform the peptide synthesis.
Peptide Cleavage
Following completion of peptide synthesis, the peptide is cleaved using a
trifluoroacetic acid (TFA) cleavage cocktail, which is composed of
TFA:TIPS:H2O:phenol in a ratio of 85:5:5:5 (v/v, or w/v for phenol).14 To begin the
cleavage, approximately 100 mg of resin with peptide attached is weighed and placed in a
glass scintillation vial. Next, the TFA cleavage cocktail is added to the resin. The vial is
wrapped in foil and placed on a shaker for 3 hours at room temperature. Afterward, the
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resin is transferred with a plastic pipette to short glass Pasteur pipette containing glass
wool. The glass wool is used as a filter to separate peptide from the resin. The filter is
rinsed with 2 mL of TFA and purged using a plastic pipette. Afterwards, the peptide
solution is dried under nitrogen gas flow until approximately ¼ of the volume remains.
The peptide product is then transferred to a 50 mL plastic centrifuge vial and is
precipitated with 25 mL of methyl-t-butyl ether:hexane solution on ice for 30 minutes.
The solution is centrifuged at 4°C for 10 minutes at approximately 1500 RPM. The
supernatant is discarded and the pellet is re-suspended in 25 mL methyl-t-butyl
ether:hexane. This procedure is repeated twice more. After the final centrifugation, the
supernatant is poured off and the pellet is dried under a low flow stream of nitrogen gas.
The final product is lyophilized overnight to a white powder from 2 mL of
acetonitrile/water.
Crude Peptide Quantitation and Purification
After the peptide has been cleaved from the resin, the amount of recovered
peptide is determined. First, 0.5 mL of TFE is added to the centrifuge tube containing the
dried peptide to dissolve the peptide and begin the quantitation process. A UV-Vis
sample is prepared from mixing 2 µL of the peptide/TFE mixture with 1.5 mL of
methanol. The UV-Vis is first run with a blank of methanol and is set to read at 280 nm.
After a sample is run, the spectra and optical density at 280 nm allows for calculation of
total milligrams of peptide present. Next, an analytical HPLC sample is prepared from a 1
µL aliquot of the peptide solution diluted to 1 mg/mL with TFE. This is injected into the
analytical HPLC and is called a “test injection.” The analytical HPLC reveals a spectrum
that indicates peptide impurities. This is useful for determining a method for collection of
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pure peptide. Another sample is prepared from the dried peptide/TFE mixture for mass
spectrometry. This is created from a 50 µL aliquot and 450 µL of additional TFE. This
sample vial is sent to the Arkansas Mass Spectrometry facility for analysis. The MALDITOF mass spectrometry profile confirms the peptide molecular mass and deuteration
pattern. Finally, the remaining peptide solution is ready for purification by semipreparative HPLC. Reversed-Phase High Performance Liquid Chromatography (RPHPLC) is run with the Hitachi L1700 system and a Zorbax RX-C8 column (9.4 mm x
250 mm) from Agilent Technology. The HPLC must initially be purged with methanol
and a desired gradient set to 92-96% for GWALP23. A test sample of 10 µL is injected
into the HPLC for determination of the peak positions on the spectrum. The time the peak
occurs corresponds to the time the peptide will be collected from the HPLC. After the test
injection, the range of the HPLC detector is changed to 10 and a 300 µL aliquot of
peptide is injected. The pure peptide product is collected approximately 15 minutes after
the injection. Once collected, the aqueous product is dried under nitrogen until only a
white film remains. Quantitation is performed again to determine the amount of pure
peptide collected. For this process, the peptide film first is dissolved in 1 mL of TFE. A
UV-Vis sample is created with 10 µL of dissolved peptide and 990 µL of methanol. The
optical density at 280 nm is used again to calculate the total mass of pure peptide in
milligrams. A sample of the peptide is sent once again to the Arkansas Mass
Spectrometry facility for analysis by MALDI-TOF mass spectrometry. This sample is
prepared using a 50 µL aliquot of peptide and 450 µL of TFE. Finally, the peptide is
aliquoted for initial sample preparation for solid-state 2H NMR and circular dichroism
spectroscopy. Solid-state 2H NMR samples require 1.3 µmol of peptide. The CD samples
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need 0.0625 µmol of peptide. The remaining pure peptide and the aqueous samples are all
dried under nitrogen until only a film remains. Lastly, any remaining pure peptide not
aliquoted for samples is lyophilized. To lyophilize, 0.5 mL of acetonitrile and 0.5 mL of
water is added to the peptide film and the solution is immersed in liquid nitrogen. The
frozen centrifuge tube is then left under vacuum overnight.
Mass Spectrometry
A MALDI-TOF (matrix-assisted laser desorption ionization, time of flight) mass
spectrum reveals the peptide mass and deuteration pattern. If correct, this pattern will
confirm the identity of the peptide created by solid-phase peptide synthesis. The mass
spectrometry is conducted by the Arkansas Statewide Mass Spectrometry Facility at the
University of Arkansas. The satellite peaks in the spectrum correspond to ionization
states of the peptide. As described in the “Crude Quantitation and Purification” section,
mass spectrometry samples can be prepared both before and after peptide purification by
semi-preparative HPLC.
Circular Dichroism Spectroscopy
Circular dichroism (CD) spectroscopy for samples in the lipid bilayer
environment may be used to confirm the secondary structure of the peptides created by
solid-state peptide synthesis. To create CD samples, peptide is incorporated into small
unilamellar lipid vesicles (SUVs) in DLPC, DMPC or DOPC lipids. These samples
require 0.0625 µmol of pure peptide, and peptide is added in a 1:40 peptide to lipid ratio.
1 mL of acetonitrile:water (50:50) solution is added to the peptide. Next, 2.5 µmols of
lipid is added to the peptide and acetonitrile:water solution. This mixture is then dried
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under nitrogen gas until a film remains. Finally, the samples are put under vacuum for
~48 hours to remove solvent.
Oriented Sample Preparation
Samples are created for analysis by NMR spectroscopy through preparation in a
1:40 peptide:lipid ratio. Samples can be prepared using DLPC, DMPC, and DOPC lipid
membranes and cholesterol. However, the focus of this project has used DOPC
phospholipids and cholesterol only. The samples are comprised of 1.3 µmols of peptide
and 90 µmols of lipid with 45% hydration (w/w-water/peptide-lipid). After the lipids are
added to dried peptide, the sample is dried under nitrogen gas. Once dry, 1 mL (95%
methanol and 5% water) is added to the dried peptide/lipid combination. To create
samples, 40 glass slides are dispersed in two petri dishes (20 glass slides per petri dish).
A 50 µL syringe is used to add 25 µL peptide/lipid solution to each glass slide. Once the
peptide/lipid solution is evenly dispersed on all slides, the open petri dishes are covered
with glass lids and dried under vacuum in a dessicator for 48 hours. The second step of
oriented sample preparation is hydrating and stacking the glass slides. Approximately 1.2
µL of deuterium-depleted water or buffer is used to hydrate the glass slides. The water
must be free of deuterium so that the only deuterium present in the system is the
deuterium-labeled alanine residues in the peptide core. The hydrating liquid is added as
approximately 3 drops to each slide. Once a slide has been hydrated with water or buffer,
it is stacked on another slide and carefully pressed down with tweezers. This pressure
helps to mechanically form a lipid bilayer stack between the slides. The final result is a
single stack of glass slides that is placed in a cuvette and sealed with a glass top using
epoxy glue. The cuvette is sealed twice to ensure a complete seal and is then placed in a
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dark heating plate at 40°C for several days to achieve orientation of liquid-crystalline
lipid bilayers. The sample is removed when it appears clear. The oriented sample
preparation process is illustrated in Figure 4.
3.
1.

50
45

2.

4.

10

40

9

35

8

30

7

25

6

β=0°

5

20
4

15
3

10
2

5
1

β=90°
Figure 4. Visual representation of oriented NMR sample preparation. (1) First, the
peptide/lipid mixture is applied to glass slides. (2) Next, the glass slides are hydrated
with deuterium-depleted water or buffer and stacked. (3) Third, the glass slides are
placed in a cuvette and sealed. (4) Finally, the oriented sample is placed in the NMR
probe at 90° or 0° with respect to the magnetic field.
31

P NMR Spectroscopy
31

P (phosphorous) NMR spectroscopy verifies bilayer alignment of oriented

samples by monitoring the lipid head groups. Samples are run at 50 °C on a Bruker
Avance 300 spectrometer at both β=0° and β=90° orientation. At β=0°, the bilayer normal
is parallel to the applied magnetic field. At β=90°, the bilayer normal is perpendicular to
the magnetic field.
Solid-State 2H NMR Spectroscopy
Solid-state 2H NMR spectroscopy is conducted similarly to 31P NMR
spectroscopy. Samples are run at 50 °C on a Bruker Avance 300 spectrometer at both
β=0° and β=90° orientations. Resulting spectra display peaks that can be used to measure
the respective 2H quadrupolar splittings. These measurements are important in
determining information about the peptide tilt and rotation in various lipid environments.
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Results
After GWALP23-R12 and

2312.3

GWALP23-R14 peptides were

+8 D

synthesized and purified, MALDI-TOF
mass spectrometry was used to confirm
the molecular mass and deuteration pattern.
+4 D

The expected molecular mass of 2304 +
~8 deuterons was confirmed for the two
peptides, as shown in Figure 5. (The
individual peaks within the “4D” (four
deuteron) and “8D” envelopes in Figure 5

Figure 5. MALDI-TOF mass spectrum
for GWALP23-R12. GWALP23-R14
gives the same spectrum because its
molecular weight and composition is
identical.

represent integral differences in the
content of 13C, which has 1.1% natural
abundance.)
Next, the peptides were
analyzed using circular dichroism
(CD) spectroscopy to confirm peptide
secondary structure. The repeating
Leu-Ala sequence of the GWALP23
peptide core forms an alpha-helical
secondary structure in the hydrophobic
region of the lipid bilayer. The CD

Figure 6. Circular dichorism spectra for
peptides in DLPC vesicles. GWALP23-R14
is shown in black and GWALP23-R12 is
shown in red. Both spectra are representative
for peptides that are alpha-helical.

spectra for both the R12 and R14 peptides shown in Figure 6 are characteristically alpha-
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helical. The helicity is indicated by the presence of minima at approximately 208 nm and
222 nm.
Phosphorous NMR (31P NMR) is used to confirm lipid bilayer alignment in
oriented samples. 31P NMR spectra display a single well-defined peak at +28 ppm for β =
0° (membrane normal parallel to the applied magnetic field) or -14 ppm for β = 90°
(membrane normal perpendicular to the applied magnetic field) for samples with proper
bilayer alignment. Smaller secondary peaks can occur in the β = 0° spectra, which
indicates some lipid unalignment. This occurs because the β = 0° orientation is more
sensitive to lipid alignment. Representative 31P spectra for three distinct peptide-lipid
conditions are displayed in Figure 7.

β=90°

β=0°

GWALP23-R14:DOPC + 10% cholesterol
(1:60)

DOPC + 20% cholesterol
(lipid only)

GWALP23-R14:DOPC + 20% cholesterol
(1:60)

Figure 7. From top spectrum: 31P NMR spectra of GWALP23-R14 with 90% DOPC
and 10% cholesterol content; DOPC with 20% cholesterol content (no peptide);
GWALP23-R14 with 80% DOPC and 20% cholesterol. Samples containing peptide and
lipid are composed in a 1:60 peptide:lipid molar ratio. Well-defined single peaks in β =
90° and β = 0° spectra indicate that the lipid bilayer is aligned.
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Peptide behavior and orientation is assessed in various bilayers by studying
oriented samples with solid-state 2H NMR spectroscopy to monitor the side-chain methyl
groups of the labeled alanine residues. Prior to the addition of cholesterol, GWALP23R14 was investigated over an extensive pH range of 2-13. This was to establish the limits
for the pKa of arginine in a lipid bilayer. The results of these experiments are displayed in
Figure 8 and indicate that the pKa of arginine is above 13.

pH 13

pH 12

pH 11.5

pH 9.0

pH 2.0

Figure 8. 2H NMR spectra of GWALP23-R14 in DOPC ester or
ether linked bilayers, over a pH range of 2-13. Samples above pH
8.5 required ether-linked lipids. Alanines 15 and 17 are deuterated
at 50% and 100%, respectively. No significant changes in the
quadrupolar splittings are observed between spectra.
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Typically, ester-linked DOPC phospholipids are the lipid of choice for creating a
model mammalian cell environment because they are natural phosphatidylcholine (PC)
lipids. However, for the results displayed in Figure 8, the extreme pH conditions would
lead to degradation of the esterlinked lipids at high or low pH,

A

by means of alkaline or acid
hydrolysis to release the acyl
chains. Ether-linked DOPC
phospholipids were discovered to

B

be suitable for replacement as
they are resistant to acid and
base-catalyzed degradation while
providing a highly similar lipid
environment. Small changes of

Figure 9. (A) 2H NMR spectra of GWALP23-R14
with ether-linked DOPC phospholipids and with
(B) ester-linked DOPC phospholipids.

0-2 kHz are observed in NMR
spectra obtained from samples with DOPC bilayers formed with ether lipids rather than
ester lipids, as shown in Figure 9.
2

H NMR experiments were then conducted at pH 5.5 to investigate the influence

of 10% cholesterol content on the GWALP23-R14 peptide. The results of this experiment
are displayed in Figure 10. No significant differences in the alanine methyl group
quadrupolar splittings were observed between GWALP23-R14 in an environment of
100% DOPC phospholipids and that of 90% DOPC and 10% cholesterol content,
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suggesting that 10% cholesterol content does not affect the charge of arginine or the
orientation and dynamic behavior of GWALP23-R14 in the bilayer membranes.

A

β=90°

β=0°

Ala-15
Ala-17

B

Figure 10. 2H NMR spectra of (A) GWALP23-R14 with 100% DOPC and (B)
GWALP23-R14 with 90% DOPC and 10% cholesterol content (B). Deuterated alanine
residues in this experiment are Ala-15 and Ala-17. There are no significant differences
in the quadrupolar splittings between spectra contained in (A) and (B).

An experiment was also conducted to investigate the influence of 20% cholesterol
on GWALP23-R14 at pH 5.5. The spectra obtained from this experiment are shown in
Figure 11. Similar to the results displayed in Fig. 10, no significant differences in
quadrupolar splittings were observed for GWALP23-R14 in an environment of 100%
DOPC phospholipids and that of 80% DOPC and 20% cholesterol content. This suggests
that 20% cholesterol content does not affect the charge of arginine or the behavior and
dynamics of GWALP23-R14.
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β=90°

β=0°

A
Ala-11
Ala-13

B

Figure 11. 2H NMR spectra of (A) GWALP23-R14 with 100% DOPC and (B)
GWALP23-R14 with 80% DOPC and 20% cholesterol content (B). Deuterated alanine
residues in this experiment are Ala-11 and Ala-13. There are no significant differences in
the quadrupolar splittings between spectra contained in (A) and (B).

Further 2H NMR experiments were conducted to investigate the influence of
cholesterol on GWALP23-R12 at pH 5.5. GWALP23-R12 has been characterized
previously in DOPC bilayers and was shown to display multi-state behavior.1 This means
that the peptide molecules exist in a variety of different orientations within the lipid
bilayer, including one populated state that moves to the membrane surface, rather than
existing in primarily one single (tilted) transmembrane orientation. Multi-state 2H NMR
spectra are characterized by low signal strength of peaks. Spectra obtained for the
GWALP23-R12 peptide in 0%, 10%, and 20% cholesterol conditions with DOPC
phospholipids are displayed in Figure 12. In the presence of 10% and 20% cholesterol,
the GWALP23-R12 helix transitions from multiple states in DOPC bilayers to instead
occupy one major state (see Discussion).
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β=90°

β=0°

A
Ala-7

B
Ala-9

C

Figure 12. 2H NMR spectra of (A) GWALP23-R12 with 100% DOPC (0%
cholesterol), (B) GWALP23-R12 with 90% DOPC and 10% cholesterol
content, and (C) GWALP23-R12 with 80% DOPC and 20% cholesterol
content. Deuterated alanine residues in this experiment are Ala-7 and Ala-9.
Spectra become more resolved in the presence of cholesterol.
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Discussion
This research project has resulted in several significant discoveries. Most notably,
the pKa of arginine in a lipid bilayer was found to be above 13. Previously, the pKa of the
arginine guanidinium group in aqueous solution has been considered to be ~12.5. This
value dates from the 1920s, is cited in biochemistry textbooks and frequently is used in
electrostatics calculations. Within the hydrophobic lipid bilayer interior, one might expect
the arginine pKa to be lower, since the pKa for lysine in a DOPC bilayer is about 4 pH
units lower than in aqueous solution.11 Nevertheless, my results indicate that the arginine
pKa remains high in the lipid bilayer environment, perhaps because other mechanisms
such as membrane deformation and helix translocation tend to ensure that hydration of
the guanidinium group is maintained.1 This finding was corroborated by a striking recent
publication which reported that the longstanding pKa of arginine in aqueous solution
should be revised to 13.8.15 The high pKa values for both aqueous and membraneincorporated arginine are particularly significant because a difference of a single pH unit
corresponds to a 10-fold change in hydrogen ion concentration.
Secondly, it was discovered that ether-linked DOPC lipids can be substituted for
ester-linked DOPC lipids in experiments that require extreme pH conditions. Spectra
obtained from samples containing ether-linked lipids are nearly indistinguishable from
spectra of samples containing ester-linked lipids. The ether-linked lipids display small
changes of 0-2 kHz in the deuterium quadrupolar splittings, but they are a suitable
replacement for ester-linked lipids due to their resistance to acid and base-catalyzed
degradation.
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Thirdly, it was found that the pKa of arginine remains high, even in the presence
of 10% and 20% cholesterol content in DOPC bilayers. The quadrupolar splittings of 2Hlabeled alanine side chains of GWALP23-R14 in a cholesterol-containing environment
were not significantly different from those in an environment without cholesterol. This
finding was particularly surprising because it is in direct opposition to the computational
findings from Cui et al., who suggested through molecular dynamics simulations that the
pKa of arginine may drop to 3.8 in the presence of cholesterol.12
Although the pKa of arginine was shown to remain unchanged in the presence of
cholesterol, in experiments with GWALP23-R12, the peptide itself was affected.
GWALP23-R12 did not exhibit its characteristic multi-state behavior in DOPC
membranes in the presence of cholesterol. With the addition of 10% and 20% cholesterol
content, 2H NMR spectra became resolved, indicating that the peptide has a single
primary orientation near the surface of the DOPC bilayers when cholesterol is present.
The cholesterol effectively seems to drive GWALP23-R12 out of the bilayer interior and
to the membrane surface.
GWALP23 peptides serve as an invaluable model for studying the role of polar
residues and transmembrane helices in a biologically relevant environment. The findings
of this project are important for advancing computational modeling of arginine and
arginine-containing proteins. For example, arginine is critical for the voltage-gating
domains of potassium channels. These channels propagate electrical signals in the
nervous system, which contribute to cellular communication. If both the pKa of arginine
in a lipid bilayer and the role of cholesterol are better understood, more accurate
computational models can be produced. This advancement is also important for drug

-26-

development. Many neurodegenerative diseases, such as Alzheimer’s and Parkinson’s,
are related to disruptions in cellular communication. If cellular function and the role of
arginine in these systems is better understood, drug development for such diseases may
be advanced.
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